/Medtronic%20Plc%20logo-by%20360b%20via%20Shutterstock.jpg)
Galway, Ireland-based Medtronic plc (MDT) develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients around the globe. With a market cap of $105.6 billion, the company operates through Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit segments.
Shares of the healthcare technology giant have lagged behind the broader market over the past 52 weeks. MDT has risen marginally over this time frame, while the broader S&P 500 Index ($SPX) has gained 8.2%. However, shares of MDT are up 3.1% on a YTD basis, compared to SPX’s 4.7% decline.